newsfilter
← Latest News
GlobeNewswire·

Acasti Pharma Reports First Quarter 2023 Operational Results

LAVAL, Québec, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST, TSXV:ACST), a late-stage, specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases, today